Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
Columbia Overseas Core Advisor COSDX
- NAV / 1-Day Return 10.16 / +0.79 %
- Total Assets 877.3 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.980%
- Distribution Fee Level Above Average
- Share Class Type No Load
- Category Foreign Large Blend
- Investment Style Large Blend
- Min. Initial Investment 2,000
- Status Open
- TTM Yield 4.61%
- Turnover 60%
USD | NAV as of May 03, 2024 | 1-Day Return as of May 03, 2024, 10:14 PM GMT+0
Morningstar’s Analysis COSDX
Will COSDX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 22.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
FCHFUSD20240513BCAP Purchased | 17.77 | 157.6 Mil | Derivative |
FEURUSD20240513CIT Purchased | 8.48 | 75.1 Mil | Derivative |
FJPYUSD20240513BCAP Purchased | 3.30 | 29.2 Mil | Derivative |
AstraZeneca PLC ADR | 3.11 | 27.5 Mil | Healthcare |
FCADUSD20240513CIT Purchased | 2.60 | 23.1 Mil | Derivative |
FTWDUSD20240513MSCO Purchased | 2.40 | 21.2 Mil | Derivative |
ING Groep NV | 2.39 | 21.2 Mil | Financial Services |
FKRWUSD20240513MSCO Purchased | 2.29 | 20.3 Mil | Derivative |
Sanofi SA | 2.25 | 20.0 Mil | Healthcare |
Novo Nordisk A/S Class B | 2.24 | 19.9 Mil | Healthcare |